3min chapter

Breakpoints cover image

#64 – Putting the Fun in Fungi: A Fun-guide to New Antifungals

Breakpoints

CHAPTER

Ibrexifunder Is FDA Approved to Treat Volovaginal Candidasis

Ibrexifunder is FDA approved to the treatment of volovaginal candidiasis, specifically in adult and post-menar goal of emails. It inhibits one, three beta D glue pan synthase which sounds an awful lot like cannons but it does interact with a unique binding site. There are no adjustments for renal or hepatic dysfunction, but there are significant drug interactions.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode